GlassScriptPhysician profile
Neel Patel
NPI 1013176999
$1,746.92
in general payments reported to CMS, 2019-2025
9 companies · $35.88 in 2025
The $35.88 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.19 · 2020: $122 · 2021: $116 · 2022: $223 · 2023: $222 · 2024: $984 · 2025: $35.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $868 · Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $867.76 |
| Food and Beverage | $374.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,494.24 | 2020-2025 | Mitraclip |
| Medtronic, INC. | $64.19 | 2021 | |
| Lantheus Medical Imaging, INC. | $54.65 | 2022-2023 | Definity |
| Angiodynamics, INC. | $52.07 | 2021 | |
| Medtronic Vascular, INC. | $25.00 | 2019 | |
| Philips North America LLC | $22.57 | 2023 | |
| Boston Scientific Corporation | $19.19 | 2019 | |
| Biosense Webster, INC. | $15.01 | 2024 | Carto 3 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neel Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.